BA
EDIT icon

Boston Advisors’s Editas Medicine EDIT Stock Holding History

Boston Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$275K Buy
12,082
+944
+8% +$23.4K 0.01% 530
2019
Q2 		$276K Buy
+11,138
New +$266K 0.01% 580
2018
Q4 		– Sell
-10,028
Closed -$319K – 640
2018
Q3 		$319K Buy
10,028
+479
+5% +$15.5K 0.01% 549
2018
Q2 		$342K Buy
+9,549
New +$338K 0.01% 562

Other funds holding EDIT

NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boston Advisors's EDIT Position: Q3 2019 in Review

Boston Advisors increased its Editas Medicine (EDIT) stake by 8.5% in Q3 2019, buying an estimated $23.4K and bringing the position to 12,082 shares worth $275K. The position accounts for 0.01% of the portfolio, ranked #530.

Boston Advisors first reported a position in EDIT in Q2 2018 and has held it in 4 quarters since. The position peaked at $342K in Q2 2018. 187 funds tracked by Wall St. Rank hold EDIT as of Q3 2019.

  • Boston Advisors held 12,082 shares of Editas Medicine worth $275K as of Q3 2019.
  • Boston Advisors bought 944 Editas Medicine shares in Q3 2019, an estimated $23.4K.
  • Editas Medicine made up 0.01% of Boston Advisors's portfolio in Q3 2019, its #530 holding.
  • Boston Advisors first reported a position in Editas Medicine in Q2 2018 and has held it in 4 quarters since.
  • Boston Advisors's Editas Medicine position peaked at $342K in Q2 2018.
  • 187 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.